Synthesis, characterisation, and in vitro evaluation of pro 2-Ile3-S-deoxo-amaninamide and pro2-D-allo- Ile3-5-deoxo-amaninamide: Implications for structure-activity relationships in amanitin conformation and toxicity
Synthesis, characterisation, and in vitro evaluation of pro 2-Ile3-S-deoxo-amaninamide and pro2-D-allo- Ile3-5-deoxo-amaninamide: Implications for structure-activity relationships in amanitin conformation and toxicity
The amatoxins are a family of toxic bicyclic peptides that inhibit RNA polymerase II. Herein we discuss an improved synthesis of these compounds from easily obtainable amino acids by means of a solid-phase methodology. Interestingly, we obtained two products of the same mass following our final macrocyclisation, relating to a similar distribution of products described in some previous reports. One of these products was the desired amatoxin ; Pro 2-Ile3-S-deoxo-amaninamide 1b. The other compound, after thorough investigation, was confirmed to be the epimer Pro2-D-allo- Ile3-S-deoxoamaninamide 1a, not an atropisomer structure as previously suggested in syntheses of related amanitin analogues. Crystallographic data of 1a confirms the presence of a βII-turn, rather than a βI-turn common to the natural toxin and 1b. This difference explains the large variation in CD spectra, although it seems to have relatively little effect on the bioactivity in vitro. These data provide new insights into the bicyclic amatoxin structure.
Amatoxin, Atropisomerism, Circular dichroism, Epimerization, Peptides
3410-3417
May, Jonathan P.
b54a262b-9f32-4435-8866-3b9c495294f3
Fournier, Pierre
ae7c1c33-1bee-46d4-84eb-779e9eb5328d
Patrick, Brian O.
44faf6ae-8ba6-4cb0-bcb7-0e7261948804
Perrin, David M.
12feb705-d3df-4f49-acf5-4283867ca47c
7 April 2008
May, Jonathan P.
b54a262b-9f32-4435-8866-3b9c495294f3
Fournier, Pierre
ae7c1c33-1bee-46d4-84eb-779e9eb5328d
Patrick, Brian O.
44faf6ae-8ba6-4cb0-bcb7-0e7261948804
Perrin, David M.
12feb705-d3df-4f49-acf5-4283867ca47c
May, Jonathan P., Fournier, Pierre, Patrick, Brian O. and Perrin, David M.
(2008)
Synthesis, characterisation, and in vitro evaluation of pro 2-Ile3-S-deoxo-amaninamide and pro2-D-allo- Ile3-5-deoxo-amaninamide: Implications for structure-activity relationships in amanitin conformation and toxicity.
Chemistry - A European Journal, 14 (11), .
(doi:10.1002/chem.200701297).
Abstract
The amatoxins are a family of toxic bicyclic peptides that inhibit RNA polymerase II. Herein we discuss an improved synthesis of these compounds from easily obtainable amino acids by means of a solid-phase methodology. Interestingly, we obtained two products of the same mass following our final macrocyclisation, relating to a similar distribution of products described in some previous reports. One of these products was the desired amatoxin ; Pro 2-Ile3-S-deoxo-amaninamide 1b. The other compound, after thorough investigation, was confirmed to be the epimer Pro2-D-allo- Ile3-S-deoxoamaninamide 1a, not an atropisomer structure as previously suggested in syntheses of related amanitin analogues. Crystallographic data of 1a confirms the presence of a βII-turn, rather than a βI-turn common to the natural toxin and 1b. This difference explains the large variation in CD spectra, although it seems to have relatively little effect on the bioactivity in vitro. These data provide new insights into the bicyclic amatoxin structure.
This record has no associated files available for download.
More information
Published date: 7 April 2008
Keywords:
Amatoxin, Atropisomerism, Circular dichroism, Epimerization, Peptides
Identifiers
Local EPrints ID: 455581
URI: http://eprints.soton.ac.uk/id/eprint/455581
ISSN: 0947-6539
PURE UUID: 19c70cbd-0305-4cca-8a7b-476922fcebf5
Catalogue record
Date deposited: 28 Mar 2022 16:38
Last modified: 17 Mar 2024 03:53
Export record
Altmetrics
Contributors
Author:
Pierre Fournier
Author:
Brian O. Patrick
Author:
David M. Perrin
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics